Prediction of perioperative myocardial infarction/injury in high-risk patients after noncardiac surgery. 2023

Rebecca Meister, and Christian Puelacher, and Noemi Glarner, and Danielle Menosi Gualandro, and Henrik A Andersson, and Mirjam Pargger, and Gabrielle Huré, and Georgiana Virant, and Daniel Bolliger, and Andreas Lampart, and Luzius Steiner, and Reka Hidvegi, and Giovanna Lurati Buse, and Christoph Kindler, and Lorenz Gürke, and Edin Mujagic, and Stefan Schaeren, and Martin Clauss, and Didier Lardinois, and Angelika Hammerer-Lercher, and Michelle Chew, and Christian Mueller, and
Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital Basel, University of Basel, Spitalstrasse 2, CH-4031 Basel, Basel-Stadt, Switzerland.

OBJECTIVE Perioperative myocardial infarction/injury (PMI) is a surprisingly common yet difficult-to-predict cardiac complication in patients undergoing noncardiac surgery. We aimed to assess the incremental value of preoperative cardiac troponin (cTn) concentration in the prediction of PMI. RESULTS Among prospectively recruited patients at high cardiovascular risk (age ≥65 years or ≥45 years with preexisting cardiovascular disease), PMI was defined as an absolute increase in high-sensitivity cTnT (hs-cTnT) concentration of ≥14 ng/L (the 99th percentile) above the preoperative concentration. Perioperative myocardial infarction/injury was centrally adjudicated by two independent cardiologists using serial measurements of hs-cTnT. Using logistic regression, three models were derived: Model 1 including patient- and procedure-related information, Model 2 adding routinely available laboratory values, and Model 3 further adding preoperative hs-cTnT concentration. Models were also compared vs. preoperative hs-cTnT alone. The findings were validated in two independent cohorts. Among 6944 patients, PMI occurred in 1058 patients (15.2%). The predictive accuracy as quantified by the area under the receiver operating characteristic curve was 0.73 [95% confidence interval (CI) 0.71-0.74] for Model 1, 0.75 (95% CI 0.74-0.77) for Model 2, 0.79 (95% CI 0.77-0.80) for Model 3, and 0.74 for hs-cTnT alone. Model 3 included 10 preoperative variables: age, body mass index, known coronary artery disease, metabolic equivalent >4, risk of surgery, emergency surgery, planned duration of surgery, haemoglobin, platelet count, and hs-cTnT. These findings were confirmed in both independent validation cohorts (n = 722 and n = 966). CONCLUSIONS Preoperative cTn adds incremental value above patient- and procedure-related variables as well as routine laboratory variables in the prediction of PMI.

UI MeSH Term Description Entries
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D006331 Heart Diseases Pathological conditions involving the HEART including its structural and functional abnormalities. Cardiac Disorders,Heart Disorders,Cardiac Diseases,Cardiac Disease,Cardiac Disorder,Heart Disease,Heart Disorder
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012372 ROC Curve A graphic means for assessing the ability of a screening test to discriminate between healthy and diseased persons; may also be used in other studies, e.g., distinguishing stimuli responses as to a faint stimuli or nonstimuli. ROC Analysis,Receiver Operating Characteristic,Analysis, ROC,Analyses, ROC,Characteristic, Receiver Operating,Characteristics, Receiver Operating,Curve, ROC,Curves, ROC,ROC Analyses,ROC Curves,Receiver Operating Characteristics
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune
D020107 Troponin T A TROPONIN complex subunit that binds to TROPOMYOSIN. There are three troponin T subtypes: troponin T1, T2 and T3. Troponin T2 is cardiac-specific whereas troponin T2 and T3 are skeletal subtypes. Troponin T2 is a BIOMARKER for damaged or injured CARDIAC MYOCYTES and mutations in troponin T2 gene are associated with FAMILIAL HYPERTROPHIC CARDIOMYOPATHY. Troponin T1,Troponin T2,Troponin T3,Troponin-T

Related Publications

Rebecca Meister, and Christian Puelacher, and Noemi Glarner, and Danielle Menosi Gualandro, and Henrik A Andersson, and Mirjam Pargger, and Gabrielle Huré, and Georgiana Virant, and Daniel Bolliger, and Andreas Lampart, and Luzius Steiner, and Reka Hidvegi, and Giovanna Lurati Buse, and Christoph Kindler, and Lorenz Gürke, and Edin Mujagic, and Stefan Schaeren, and Martin Clauss, and Didier Lardinois, and Angelika Hammerer-Lercher, and Michelle Chew, and Christian Mueller, and
January 2015, Swiss medical weekly,
Rebecca Meister, and Christian Puelacher, and Noemi Glarner, and Danielle Menosi Gualandro, and Henrik A Andersson, and Mirjam Pargger, and Gabrielle Huré, and Georgiana Virant, and Daniel Bolliger, and Andreas Lampart, and Luzius Steiner, and Reka Hidvegi, and Giovanna Lurati Buse, and Christoph Kindler, and Lorenz Gürke, and Edin Mujagic, and Stefan Schaeren, and Martin Clauss, and Didier Lardinois, and Angelika Hammerer-Lercher, and Michelle Chew, and Christian Mueller, and
February 2021, The Canadian journal of cardiology,
Rebecca Meister, and Christian Puelacher, and Noemi Glarner, and Danielle Menosi Gualandro, and Henrik A Andersson, and Mirjam Pargger, and Gabrielle Huré, and Georgiana Virant, and Daniel Bolliger, and Andreas Lampart, and Luzius Steiner, and Reka Hidvegi, and Giovanna Lurati Buse, and Christoph Kindler, and Lorenz Gürke, and Edin Mujagic, and Stefan Schaeren, and Martin Clauss, and Didier Lardinois, and Angelika Hammerer-Lercher, and Michelle Chew, and Christian Mueller, and
October 2011, Annals of internal medicine,
Rebecca Meister, and Christian Puelacher, and Noemi Glarner, and Danielle Menosi Gualandro, and Henrik A Andersson, and Mirjam Pargger, and Gabrielle Huré, and Georgiana Virant, and Daniel Bolliger, and Andreas Lampart, and Luzius Steiner, and Reka Hidvegi, and Giovanna Lurati Buse, and Christoph Kindler, and Lorenz Gürke, and Edin Mujagic, and Stefan Schaeren, and Martin Clauss, and Didier Lardinois, and Angelika Hammerer-Lercher, and Michelle Chew, and Christian Mueller, and
July 1994, The American journal of the medical sciences,
Rebecca Meister, and Christian Puelacher, and Noemi Glarner, and Danielle Menosi Gualandro, and Henrik A Andersson, and Mirjam Pargger, and Gabrielle Huré, and Georgiana Virant, and Daniel Bolliger, and Andreas Lampart, and Luzius Steiner, and Reka Hidvegi, and Giovanna Lurati Buse, and Christoph Kindler, and Lorenz Gürke, and Edin Mujagic, and Stefan Schaeren, and Martin Clauss, and Didier Lardinois, and Angelika Hammerer-Lercher, and Michelle Chew, and Christian Mueller, and
February 2021, The Canadian journal of cardiology,
Rebecca Meister, and Christian Puelacher, and Noemi Glarner, and Danielle Menosi Gualandro, and Henrik A Andersson, and Mirjam Pargger, and Gabrielle Huré, and Georgiana Virant, and Daniel Bolliger, and Andreas Lampart, and Luzius Steiner, and Reka Hidvegi, and Giovanna Lurati Buse, and Christoph Kindler, and Lorenz Gürke, and Edin Mujagic, and Stefan Schaeren, and Martin Clauss, and Didier Lardinois, and Angelika Hammerer-Lercher, and Michelle Chew, and Christian Mueller, and
January 1992, International anesthesiology clinics,
Rebecca Meister, and Christian Puelacher, and Noemi Glarner, and Danielle Menosi Gualandro, and Henrik A Andersson, and Mirjam Pargger, and Gabrielle Huré, and Georgiana Virant, and Daniel Bolliger, and Andreas Lampart, and Luzius Steiner, and Reka Hidvegi, and Giovanna Lurati Buse, and Christoph Kindler, and Lorenz Gürke, and Edin Mujagic, and Stefan Schaeren, and Martin Clauss, and Didier Lardinois, and Angelika Hammerer-Lercher, and Michelle Chew, and Christian Mueller, and
January 2024, Frontiers in cardiovascular medicine,
Rebecca Meister, and Christian Puelacher, and Noemi Glarner, and Danielle Menosi Gualandro, and Henrik A Andersson, and Mirjam Pargger, and Gabrielle Huré, and Georgiana Virant, and Daniel Bolliger, and Andreas Lampart, and Luzius Steiner, and Reka Hidvegi, and Giovanna Lurati Buse, and Christoph Kindler, and Lorenz Gürke, and Edin Mujagic, and Stefan Schaeren, and Martin Clauss, and Didier Lardinois, and Angelika Hammerer-Lercher, and Michelle Chew, and Christian Mueller, and
March 1998, Anesthesiology,
Rebecca Meister, and Christian Puelacher, and Noemi Glarner, and Danielle Menosi Gualandro, and Henrik A Andersson, and Mirjam Pargger, and Gabrielle Huré, and Georgiana Virant, and Daniel Bolliger, and Andreas Lampart, and Luzius Steiner, and Reka Hidvegi, and Giovanna Lurati Buse, and Christoph Kindler, and Lorenz Gürke, and Edin Mujagic, and Stefan Schaeren, and Martin Clauss, and Didier Lardinois, and Angelika Hammerer-Lercher, and Michelle Chew, and Christian Mueller, and
March 2018, Circulation,
Rebecca Meister, and Christian Puelacher, and Noemi Glarner, and Danielle Menosi Gualandro, and Henrik A Andersson, and Mirjam Pargger, and Gabrielle Huré, and Georgiana Virant, and Daniel Bolliger, and Andreas Lampart, and Luzius Steiner, and Reka Hidvegi, and Giovanna Lurati Buse, and Christoph Kindler, and Lorenz Gürke, and Edin Mujagic, and Stefan Schaeren, and Martin Clauss, and Didier Lardinois, and Angelika Hammerer-Lercher, and Michelle Chew, and Christian Mueller, and
May 2018, Circulation,
Copied contents to your clipboard!